Rizatriptan Benzoate Tablet, Orally Disintegrating
NDC Package 71205-557-06
Package Information
Rizatriptan Benzoate tablets is rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old.Limitations of Use•Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 71205-557 and is authorized under FDA application ANDA203062.
Identification & Billing
- RxCUI: 312837 - rizatriptan benzoate 10 MG Disintegrating Oral Tablet
- RxCUI: 312837 - rizatriptan 10 MG Disintegrating Oral Tablet
- RxCUI: 312837 - rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Disintegrating Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71205 - Proficient Rx Lp
- 71205-557 - Rizatriptan Benzoate
- 71205-557-06 - 1 BLISTER PACK in 1 BAG / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
- 71205-557 - Rizatriptan Benzoate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71205-557-06 identifies a specific commercial package of 1 blister pack in 1 bag / 6 tablet, orally disintegrating in 1 blister pack of Rizatriptan Benzoate, a human prescription drug labeled by Proficient Rx Lp. This product is billed for "EA" each discreet unit and contains an estimated amount of 6 billable units per package. This tablet, orally disintegrating is formulated for oral use and contains rizatriptan benzoate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on July 01, 2013. The current certification is valid through December 31, 2027.
How is this Proficient Rx Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71205055706. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.